Viewing StudyNCT00354263



Ignite Creation Date: 2024-05-05 @ 4:56 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00354263
Status: COMPLETED
Last Update Posted: 2008-04-24
First Post: 2006-07-19

Brief Title: Phase I Study of IMP321 Given Alone or as an Adjuvant to a Reference Flu Antigen
Sponsor: Immutep SAS
Organization: Immutep SAS

Conditions & Keywords Data

Conditions:
Name
Healthy
Keywords:
Name View
PharmacokineticsPharmacodynamics View
Healthy male volunteers View
IMP321 View
Adjuvant View
Monotherapy View